Each colour maps a published value to the exact source passage used to support it. Only bounded excerpts are public; administrators can inspect the complete captured source.
Title
Roche scales NVIDIA AI factories globally to accelerate drug discovery, diagnostics and manufacturing
Roche Scales NVIDIA AI Factories Globally to Accelerate Drug Discovery, Diagnostic Solutions and Manufacturing Breakthroughs | NVIDIA Blog Skip to content Roche Scales NVIDIA AI Factories Globally to Acce…
Description
Roche is deploying more than 3,500 NVIDIA Blackwell GPUs across hybrid cloud and on-premises environments in the U.S. and Europe, expanding an existing collaboration to turn AI and accelerated computing into a core operating capability across its pharmaceutical and diagnostics businesses. AI is central to Genentech's Lab-in-the-Loop drug discovery strategy, where nearly 90% of eligible small-molecule programs integrate AI; in one program a degrader molecule for oncology was designed 25% faster, and in another AI helped deliver a backup drug candidate in seven months instead of more than two years. Roche is also using NVIDIA Omniverse to build digital twins of manufacturing sites, including its new GLP-1 facility in North Carolina, uses NVIDIA Parabricks software to enable insights across vast datasets, is evaluating the BioNeMo platform for molecular design and chemistry innovation, and uses NVIDIA NeMo Guardrails to ensure safe and reliable healthcare-grade AI.
…Your browser does not support the video tag. Share X Facebook LinkedIn Email 0 Roche is deploying more than 3,500 NVIDIA Blackwell GPUs across hybrid cloud and on‑premises environments in the U.S. and Europe, expanding on an existing collaboration to turn AI and accelerated computing into a core operating capability across its pharmaceutical and diagnostics businesses. At NVIDIA GTC today, Roche unveiled how this new AI computing backbone will pow…
…data and AI are connected in an iterative loop to tackle the hardest problems. Nearly 90% of Genentech’s eligible small‑molecule programs integrate AI. In one program, a degrader molecule for oncology was designed 25% faster, and in another program, AI helped deliver a backup molecule — a secondary drug candidate developed in parallel to mitigate costly risks of failure of the first one — in seven months instead of more than two years. With NVIDIA Blackwell and the NVIDIA BioNeMo platform running on its AI factori…
Company
Roche
…Your browser does not support the video tag. Share X Facebook LinkedIn Email 0 Roche is deploying more than 3,500 NVIDIA Blackwell GPUs across hybrid cloud and on‑premises environments in the U.S. and Europe, expanding on an existing collaboration to turn AI and accelerated computing in…
Region
Global
…The leader in healthcare is 'doing now what patients need next,' with a new deployment spanning more than 3,500 NVIDIA Blackwell GPUs across its worldwide operations and embedded across the entire value chain, massively scaling R&D productivity, next-generation diagnostics and manufactur…
Industry
Pharmaceuticals
…aboration to turn AI and accelerated computing into a core operating capability across its pharmaceutical and diagnostics businesses. At NVIDIA GTC today, Roche unveiled how this new AI computing backbone will po…
Problem
“When we talk about collapsing time, we’re really talking about the patients and their families who are waiting,” said Mamilli. “As an innovation-led company, using AI for this work is deeply meaningful and purpose-driven; it is exactly what we are here to do.”
…covery engine, and the new infrastructure will accelerate this process further. “When we talk about collapsing time, we’re really talking about the patients and their families who are waiting,” said Mamilli. “As an innovation-led company, using AI for this work is deeply meaningful and purpose-driven; it is exactly what we are here to do.” In drug discovery, AI is at the heart of Genentech’s Lab-in-the-Loop strategy,…
Solution
Roche is deploying more than 3,500 NVIDIA Blackwell GPUs across hybrid cloud and on-premises environments in the U.S. and Europe, expanding on an existing collaboration to turn AI and accelerated computing into a core operating capability across its pharmaceutical and diagnostics businesses. With NVIDIA Blackwell and the NVIDIA BioNeMo platform running on its AI factories, Roche can train and fine-tune biological and molecular foundation models, integrate proprietary datasets and expand AI-driven lab automation, all powering Genentech's Lab-in-the-Loop drug discovery strategy. Roche is also modernizing pharmaceutical manufacturing with NVIDIA Omniverse libraries, building digital twins of production facilities to simulate and optimize complex systems before they go live, including its new GLP-1 manufacturing facility in North Carolina. Accelerated computing and NVIDIA Parabricks software enable insights across vast datasets, and in digital health Roche uses NVIDIA NeMo Guardrails to ensure safe and reliable healthcare-grade AI.
…s of failure of the first one — in seven months instead of more than two years. With NVIDIA Blackwell and the NVIDIA BioNeMo platform running on its AI factories, Roche can train and fine‑tune biological and molecular foundation models, integrate proprietary datasets and expand AI‑driven lab automation, all powering the Lab-in-the-Loop. This allows Roche to explore far larger swaths of the biological and chemical s…
…th greater speed. Driving Pharmaceutical Manufacturing Powered by Digital Twins Roche is also modernizing pharmaceutical manufacturing with NVIDIA Omniverse libraries, building digital twins of production facilities to simulate and optimize complex systems before they go live. These virtual environments are already helping accelerate the development of Ro…
Business value
Nearly 90% of Genentech's eligible small-molecule programs integrate AI. In one program, a degrader molecule for oncology was designed 25% faster, and in another program, AI helped deliver a backup molecule — a secondary drug candidate developed in parallel to mitigate costly risks of failure of the first one — in seven months instead of more than two years.
…data and AI are connected in an iterative loop to tackle the hardest problems. Nearly 90% of Genentech’s eligible small‑molecule programs integrate AI. In one program, a degrader molecule for oncology was designed 25% faster, and in another program, AI helped deliver a backup molecule — a secondary drug candidate developed in parallel to mitigate costly risks of failure of the first one — in seven months instead of more than two years. With NVIDIA Blackwell and the NVIDIA BioNeMo platform running on its AI factori…
AI capabilities
Generative AI, Predictive Analytics, Computer Vision
…lackwell and the NVIDIA BioNeMo platform running on its AI factories, Roche can train and fine‑tune biological and molecular foundation models, integrate proprietary datasets and expand AI‑driven lab automation, all poweri…
…computing and NVIDIA Parabricks software enable insights across vast datasets. In digital pathology, NVIDIA technologies scan a large number of images to detect subtle disease patterns. In digital health, Roche uses NVIDIA NeMo Guardrails to ensure safe and reliabl…
Business functions
Research & Development, Manufacturing & Production
…are solutions, moving AI from isolated pilots to an enterprise‑wide capability. Harnessing Drug Discovery for Breakthroughs at a New Scale AI is already transforming Roche and Genentech’s discovery engine, and the new…
…th greater speed. Driving Pharmaceutical Manufacturing Powered by Digital Twins Roche is also modernizing pharmaceutical manufacturing with NVIDIA Omniverse libraries, building digital twins of production facilities to simulate and optimize compl…
Technology
NVIDIA Blackwell, NVIDIA BioNeMo, NVIDIA Omniverse, NVIDIA Parabricks, NVIDIA NeMo Guardrails
…s of failure of the first one — in seven months instead of more than two years. With NVIDIA Blackwell and the NVIDIA BioNeMo platform running on its AI factories, Roche can train and fine‑tune biological and molecular foundation models, inte…
…solutions and help patients make better informed choices for their healthcare. Accelerated computing and NVIDIA Parabricks software enable insights across vast datasets. In digital pathology, NVIDIA technologies scan a large number of images to dete…
…a large number of images to detect subtle disease patterns. In digital health, Roche uses NVIDIA NeMo Guardrails to ensure safe and reliable healthcare-grade AI. Roche is also evaluating the BioNeMo platform for developing AI models to supp…
Deployment model
cloud, onPremise, hybrid
…Your browser does not support the video tag. Share X Facebook LinkedIn Email 0 Roche is deploying more than 3,500 NVIDIA Blackwell GPUs across hybrid cloud and on‑premises environments in the U.S. and Europe, expanding on an existing collaboration to turn AI and accelerated computing in…
Deployment options
cloud, On-premise, hybrid
…Your browser does not support the video tag. Share X Facebook LinkedIn Email 0 Roche is deploying more than 3,500 NVIDIA Blackwell GPUs across hybrid cloud and on‑premises environments in the U.S. and Europe, expanding on an existing collaboration to turn AI and accelerated computing in…
